US PA Philadelphia Falk MJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{MiPNetLab | {{MiPNetLab | ||
|address=[[Falk MJ|Falk Marni | |address=[[Falk MJ|Falk Marni Joy]], PhD, Assistant Prof. | ||
The Children's Hospital of Philadelphia | The Children's Hospital of Philadelphia | ||
| Line 14: | Line 14: | ||
|state=Pennsylvania (PA) | |state=Pennsylvania (PA) | ||
|country=USA | |country=USA | ||
|weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ] | |||
|MiPNetLab=Falk MJ, Polyak E | |MiPNetLab=Falk MJ, Polyak E | ||
|keyword=Respiratory chain disease | |keyword=Respiratory chain disease | ||
Revision as of 11:35, 13 August 2012
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
